Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study
CONCLUSIONS: Non-Hispanic Black women showed a decreased risk of death with the addition of bevacizumab and patients of Asian ancestry had a lower death rate than all other minority groups, but despite these clinically meaningful improvements there was no statistically significant difference in OS among the groups.PMID:34857397 | DOI:10.1016/j.ygyno.2021.11.013
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Nefertiti C duPont Danielle Enserro Mark F Brady Katherine Moxley Joan L Walker Casey Cosgrove Kristin Bixel Krishnansu S Tewari Premal Thaker Andrea E Wahner Hendrickson Stephen Rubin Keiichi Fujiwara A Catherine Casey John Soper Robert A Burger Bradley Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Epithelial Cancer | Fallopian Tube Cancer | Hematology | Ovarian Cancer | Ovaries | Statistics | Study | Women